Full Text View
Tabular View
No Study Results Posted
Related Studies
Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
This study has been completed.
Study NCT00732771   Information provided by Novartis

First Received on August 5, 2008.   Last Updated on August 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Hyperaldosteronism
Additional conditions recognized in this trial
Hyperaldosteronism
More general conditions related to this trial
Adrenal Gland Diseases
Adrenocortical Hyperfunction
Endocrine System Diseases
Interventions listed in this trial
LCI699
Sponsors listed in this trial
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services